doc. MUDr. Petr Szturz, Ph.D.

Curriculum vitae

Department/Faculty/University

• Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, School of Medicine

Function, current position

• Medical Oncology Specialist (Division of Solid Tumor Oncology), Associate Professor

Education and academic qualifications

• 2016: Associate Professor of Oncology
• 2015: ESMO Examination in Medical Oncology
• 2009-2014: Specialty Training in Medical Oncology
• 2010-2012: Ph.D. in Oncology
  Thesis: "New diagnostic and therapeutic methods in selected rare hematooncological diagnoses"
• 2003-2009: M.D. in General Medicine (passed with honours)
  

Professional experience

• Since 2010: Lecturer
  Masaryk University, School of Medicine
• Since 2009: Physician
  Department of Internal Medicine, Hematology and Oncology, University Hospital Brno

Teaching activities

• Internal Medicine, Oncology

Academic activities

• 90 scientific publications (of which 41 as the first author)
• 57 cumulative impact factor
• 175 citations
• Projects:
  Evaluation of MET Expression and Inhibition in Squamous Cell Carcinomas of the Head and Neck (ESMO)
  Register of Very Rare Hematooncologic Diseases in Adult Patients (SUp FNB 2/14)
  Internet Portal for Very Rare Hematologic and Oncologic Diseases (23/14/NAP)

Internship and stays for the purpose of study or work

• 2015-2016: ESMO Translational Research Fellowship at the Bichat-Beaujon University Hospital in Paris, France
• 2014: ESMO Clinical Unit Visit fellowship at the Antwerp University Hospital in Belgium
• 2007-2008: Medical University of Vienna and the Vienna General Hospital, Austria under the Socrates/Erasmus programme
• 2007: Kliniken Erlabrunn in Germany (surgery, internal medicine)

Research interests

• Head & Neck Cancer
• Translational Research
• Very Rare Diseases - Histiocytic disorders, Castleman disease, Skin manifestations of monoclonal gammopathies, Vasculopathies

Professional Society Memberships

• European Society for Medical Oncology
• Czech Society of Internal Medicine
• Czech Society for Oncology
• Czech Society of Hematology

Awards Related to Science and Research

• 2013: Young Investigators' Award during the DGHO 2013 Congress in Vienna
• 2013: 1st place for the best original article in 2012 from the Czech Society of Internal Medicine
• 2011: Paul Janssen Award for the most outstanding publication contribution to multiple myeloma

Peer-reviewed journals with IF (first or corresponding author):

• SZTURZ, Petr, E. RAYMOND a S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. Oral oncology. AMSTERDAM: ELSEVIER SCIENCE BV, 2016, roč. 59, AUG 2016, s. "E12"-"E14", 3 s. ISSN 1368-8375. Dostupné z: https://dx.doi.org/10.1016/j.oraloncology.2016.05.017. URL info
• SZTURZ, Petr, Pol SPECENIER, Carl VAN LAER, Danielle VAN DEN WEYNGAERT, Bob CORTHOUTS, Laurens CARP, Eric VAN MARCK, Olivier VANDERVEKEN a Jan B. VERMORKEN. Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology and Head & Neck. NEW YORK: SPRINGER, 2016, roč. 273, č. 6, s. 1629-1636. ISSN 0937-4477. Dostupné z: https://dx.doi.org/10.1007/s00405-015-3673-y. info
• SZTURZ, Petr a S. FAIVRE. Letter to the editor referring to the publication entitled “The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment” by Pai et al. Oral Oncology. Amsterdam: Elsevier Science BV, 2016, roč. 62, "neuvedeno", s. "e3"-"e4", 2 s. ISSN 1368-8375. Dostupné z: https://dx.doi.org/10.1016/j.oraloncology.2016.08.007. info
• ŘEHÁK, Zdeněk a Petr SZTURZ. Comment on: FDG PET in the early diagnosis of large-vessel vasculitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER, 2014, roč. 41, č. 3, s. 579-580. ISSN 1619-7070. Dostupné z: https://dx.doi.org/10.1007/s00259-013-2662-x. info
• ŘEHÁK, Zdeněk, Petr SZTURZ, Leoš KŘEN, Zdeněk FOJTÍK a Jaroslav STANÍČEK. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries. CLINICAL NUCLEAR MEDICINE. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2014, roč. 39, č. 1, s. "e84"-"e86", 3 s. ISSN 0363-9762. Dostupné z: https://dx.doi.org/10.1097/RLU.0b013e3182868aae. info
• SZTURZ, Petr. Very rare diseases in oncology. Medical oncology. Totowa: HUMANA PRESS INC, 2014, roč. 31, č. 5, s. 947-948. ISSN 1357-0560. Dostupné z: https://dx.doi.org/10.1007/s12032-014-0947-y. info
• SZTURZ, Petr, Zdeněk ADAM, Z. ŘEHÁK a Renata KOUKALOVÁ. Xanthelasma palpebrarum responding to interleukin-1 blockade. Internal medicine journal. Hoboken: Wiley-Blackwell, 2014, roč. 44, č. 6, s. 617-618. ISSN 1444-0903. Dostupné z: https://dx.doi.org/10.1111/imj.12441. info
• SZTURZ, Petr, M. PRÁŠEK, Z. ŘEHÁK a P. FABIAN. Unicentric Castleman disease: from screening mammography to PET/CT imaging. Nuklearmedizin-Nuclear Medicine. Stuttgart: Schattauer GmbH-Verlag Medizin Naturwissenschaften, 2014, roč. 53, č. 5, s. "N41"-"N43", 3 s. ISSN 0029-5566. info
• SZTURZ, Petr, Zdeněk ADAM, Vladimír VAŠKŮ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2013, roč. 54, č. 6, s. 1324-1326. ISSN 1042-8194. Dostupné z: https://dx.doi.org/10.3109/10428194.2012.738816. info
• SZTURZ, Petr, Libor HLAVATÝ, Jiří PRÁŠEK a Dana DVOŘÁKOVÁ. Erdheim-Chester disease and Schnitzler syndrome: so near, and yet so far. USA: Springer, 2013. Dostupné z: https://dx.doi.org/10.1007/s12185-013-1437-2. info
• ADAM, Zdeněk, Petr SZTURZ, Jiří VANÍČEK, Mojmír MOULIS, Luděk POUR, Marta KREJČÍ, Roman HÁJEK a Jiří MAYER. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Acta Oncologica. LONDON: INFORMA HEALTHCARE, 2013, roč. 52, č. 5, s. 994-1001. ISSN 0284-186X. Dostupné z: https://dx.doi.org/10.3109/0284186X.2012.716164. info
• SZTURZ, Petr, Zdeněk ADAM, Zdenek REHAK, Renata KOUKALOVÁ, Leoš KŘEN, Mojmír MOULIS, Marta KREJČÍ a Jiří MAYER. Salvage lenalidomide in four rare oncological diseases. Tumori. Roma: PENSIERO SCIENTIFICO EDITOR, 2013, roč. 99, č. 5, s. "e251"-"e256", 6 s. ISSN 0300-8916. Dostupné z: https://dx.doi.org/10.1700/1377.15326. URL info
• SZTURZ, Petr, Zdeněk ADAM, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Radka ŠLAISOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Martin KLABUSAY, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncologica. 2012, roč. 51, č. 3, s. 412-415. ISSN 0284-186X. Dostupné z: https://dx.doi.org/10.3109/0284186X.2011.631581. info
• SZTURZ, Petr, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Zdeněk ADAM, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Jiří VANÍČEK, Tomáš NEBESKÝ, Roman HÁJEK a Jiří MAYER. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Nuclear Medicine and Biology. 2012, roč. 39, č. 3, s. 429-436. ISSN 0969-8051. Dostupné z: https://dx.doi.org/10.1016/j.nucmedbio.2011.10.002. info
• ŘEHÁK, Zdeněk, Petr SZTURZ, Eva KREJČÍ a Ilona KOCÁKOVÁ. FDG-PET-Positive Foreign-Body Granuloma Mimicking Residual Germinal Tumor Infiltration. Clinical Nuclear Medicine. 2012, roč. 37, č. 8, s. 790-792. ISSN 0363-9762. Dostupné z: https://dx.doi.org/10.1097/RLU.0b013e3182485291. info
• SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Josef FEIT, Leoš KŘEN, Zdeněk FOJTÍK, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, roč. 53, č. 4, s. 743-745. ISSN 1042-8194. Dostupné z: https://dx.doi.org/10.3109/10428194.2011.627482. info
• SZTURZ, Petr, Zdeněk ADAM, Jana CHOVANCOVÁ, Olga STEHLÍKOVÁ, Martin KLABUSAY, Z. ŘEHÁK, R. KOUKALOVÁ, Lenka ZAHRADOVÁ, Marta KREJČÍ, Luděk POUR, Roman HÁJEK a Jiří MAYER. Lenalidomide: a new treatment option for Castleman disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, roč. 53, č. 10, s. 2089-2091. ISSN 1042-8194. Dostupné z: https://dx.doi.org/10.3109/10428194.2011.621564. info
• SZTURZ, Petr, Zdeněk ADAM, Roman HÁJEK a Jiří MAYER. Successful Anakinra Therapy in 2 Patients with Schnitzler Syndrome. Onkologie. Switzerland: Karger, 2011, roč. 34, č. 5, s. 265-268. ISSN 0378-584X. Dostupné z: https://dx.doi.org/10.1159/000327816. URL info
• SZTURZ, Petr, Zdeněk ADAM, Mária KLINCOVÁ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Vladimír VAŠKŮ, Roman HÁJEK a Jiří MAYER. Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen. Clinical Lymphoma, Myeloma & Leukemia. 2011, roč. 11, č. 6, s. 517-520. ISSN 2152-2650. Dostupné z: https://dx.doi.org/10.1016/j.clml.2011.06.014. info

2016/09/04